- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
National Biologics Manufacturing Center Launched in UK
October 01, 2015.
Instigated as part of the Strategy for Life Science, the new £38m ($57.5m) National Biologics Manufacturing Centre opened in Darlington, UK, today.
The Centre is built around six core themes to help companies of all sizes translate their ideas, research and knowledge into commercial business propositions. It will provide companies with open access facilities and expertise to help them develop, prove and commercialize new and improved processes and technologies for biologics manufacture.
Launching the Centre, Jo Johnson MP, Minister of State for Universities and Science said, “We want the UK to be the best place in Europe to innovate ... [T]he Centre will bridge the gap between business and academia and help to turn great ideas into commercial reality.”
